Sign In
Buy ACON
$3.49
-0.0100 (-0.286%)
At Close: Jun 03, 2026
Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer Pain Session Co-Moderator Doug Beall, M.D. underscored that dis
Aclarion to Present at the LD Micro Main Event XIX
06:00am, Thursday, 09'th Oct 2025
Presentation on Monday, October 20, 2025 at 12:00 PM PT Broomfield, Colorado--(Newsfile Corp. - October 9, 2025) - Aclarion, Inc. (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a health
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
06:02am, Tuesday, 07'th Oct 2025
Company recognized for breakthrough Nociscan solution for chronic low back pain, one of the most widespread health challenges BROOMFIELD, Colo., October 7, 2025 – PRISM MediaWire (Press Release Serv
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
06:00am, Tuesday, 07'th Oct 2025
BROOMFIELD, Colo., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and prop
Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers
07:23am, Wednesday, 01'st Oct 2025
BROOMFIELD, Colo., October 1, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc.
Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers
07:17am, Wednesday, 01'st Oct 2025
BROOMFIELD, Colo., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and prop
First Patients Enrolled at UHealth – University of Miami in Aclarion's Pivotal CLARITY Trial
06:01am, Thursday, 25'th Sep 2025
BROOMFIELD, Colo., September 25, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a heal
Aclarion Appoints Greg Gould as Chief Financial Officer
06:01am, Wednesday, 03'rd Sep 2025
HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations to $
Aclarion Appoints Greg Gould as Chief Financial Officer
06:00am, Wednesday, 03'rd Sep 2025
HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations to $
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
06:03am, Tuesday, 05'th Aug 2025
BROOMFIELD, Colo., August 05, 2025 – PRISM MediaWire – Aclarion, Inc.
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
06:00am, Tuesday, 05'th Aug 2025
Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume g
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
04:01pm, Monday, 07'th Jul 2025
Meeting adjourned to Monday, July 21, 2025 at 9:30 a.m. Mountain Time Broomfield, CO, July 7, 2025 – PRISM MediaWire – Aclarion, Inc.
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
04:01pm, Monday, 07'th Jul 2025
Meeting adjourned to Monday, July 21, 2025 at 9:30 a.m. Mountain Time BROOMFIELD, Colo.
First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial
06:00am, Wednesday, 25'th Jun 2025
BROOMFIELD, Colo., June 25, 2025 – PRISM MediaWire – Aclarion, Inc.
First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial
06:00am, Wednesday, 25'th Jun 2025
The first CLARITY patient was enrolled at the Texas Back Institute, a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial
